Pasithea Therapeutics Corp's total assets for Q4 2025 were $60.24B, an increase of 441845.27% from the previous quarter. KTTA total liabilities were $5.02B for the fiscal quarter, a 352490.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.